For the Inventor, By the Inventor

Enter assignee name

Plymouth Meeting, PA, United States of America

Inovio Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 93

% Expired Patents = 1.1

CIPO Patents = 10

EPO Patents = 42

Trademarks = 5

Forward Citations = 54

Loading Chart...

Loading Chart...

73 inventors (with patents filed for the assignee):

David B Weiner (54 out of 197 patents)

Jian Yan (47 out of 73 patents)

Niranjan Y Sardesai (23 out of 30 patents)

4. Kate Broderick (17 out of 21 patents)

5. Stephen V Kemmerrer (15 out of 19 patents)

6. Karuppiah Muthumani (14 out of 30 patents)

7. Anna Slager (13 out of 13 patents)

8. Neil Cooch (11 out of 11 patents)

9. Bradley Garman (10 out of 10 patents)

10. Bernadette Ferraro (10 out of 12 patents)

11. Jay R McCoy (10 out of 29 patents)

12. Matthew P Morrow (8 out of 23 patents)

13. Mathura P Ramanathan (8 out of 14 patents)

14. Jewell Walters (6 out of 7 patents)

15. Ruxandra Draghia-Akli (5 out of 28 patents)

Core Competencies:

Cancer Vaccines

Electroporation Devices

MUC16

Survivin

BORIS

DNA Antibody Constructs

Immunotherapy

Intradermal Injection

Vaccine Adjuvants

Nucleic Acid Constructs

RSV Antibodies

FMDV Vaccines

93 patents: Sort by Forward Citations

1. 12679904 - CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF (2026-07-14),

2. 12668616 - WT1 VACCINE (2026-06-30),

3. 12667716 - Vacuum-assisted electroporation devices, and related systems and methods (2026-06-30),

4. D1128906 - Hand-held electroporation device (2026-06-02),

5. 12623074 - Electroporation device with detachable needle array with lock-out system (2026-05-12),

6. 12491361 - Tolerable and minimally invasive skin electroporation device (2025-12-09),

7. 12478667 - Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same (2025-11-25),

8. 12350318 - Combination therapy to treat brain cancer (2025-07-08),

9. 12285473 - Cancer vaccines targeting MUC16 and uses thereof (2025-04-29),

10. 12280108 - Vaccines having an antigen and interleukin-21 as an adjuvant (2025-04-21),

11. 12251561 - Minimally invasive dermal electroporation device (2025-03-18),

12. 12240872 - Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same (2025-03-04),

13. 12161706 - Cancer vaccines targeting BORIS and uses thereof (2024-12-10),

14. 12128229 - Oral mucosal electroporation device and use thereof (2024-10-29),

15. 12109258 - Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections (2024-10-08),

Company Overview

Inovio Pharmaceuticals, Inc., based in Plymouth Meeting, PA, specializes in the development of innovative cancer vaccines and immunotherapy solutions. The company focuses on harnessing advanced technologies such as electroporation devices and DNA antibody constructs to enhance therapeutic efficacy. Inovio's research prominently features targets like MUC16, Survivin, and BORIS, aiming to improve treatment outcomes through intradermal injection methods. Their commitment to pioneering cancer treatment positions them as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

93 Patents

#2 in Plymouth Meeting, PA

#157 in Pennsylvania

#4,044 in US

#8,313 in the World

Plymouth Meeting, PA, United States of America

Inovio Pharmaceuticals, Inc.

Forward Citations = 54

73 inventors:

David B Weiner (54 out of 197 patents)

Jian Yan (47 out of 73 patents)

Niranjan Y Sardesai (23 out of 30 patents)

4. Kate Broderick (17 out of 21 patents)

5. Stephen V Kemmerrer (15 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inovio Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/inovio-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…